Actively Recruiting

Age: 18Years - 90Years
All Genders
Healthy Volunteers
ID01293110

Database of Patients With Lower Urinary Tract Dysfunction Treated at the University of Zürich

Led by University of Zurich · Updated on 2025-04-03

7000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Lower urinary tract dysfunction affects patients with neurological diseases or injuries and often leads to symptoms that negatively impact their quality of life. This condition includes problems such as detrusor overactivity, detrusor sphincter dyssynergia, voiding dysfunction, and stress incontinence. Treatments can be challenging because conventional options may not always be successful. The study collects data to better understand and manage this condition in patients treated at the University of Zurich. The research involves prospectively gathering clinical, video-urodynamic, and radiological information from patients with neurogenic lower urinary tract dysfunction at the University of Zurich. There are no specific treatment interventions in this observational study; instead, data on patient conditions and outcomes are systematically recorded over time. This allows long-term follow-up to help maintain continence and preserve kidney function. Participants provide written informed consent and undergo urodynamic examinations as part of their care. Researchers collect various clinical and imaging data to monitor patients' health status, including survival from the first visit until death. The study supports ongoing evaluation of patient outcomes and treatment effectiveness through a structured database, with a planned end date in January 2030.

CONDITIONS

Brief Title

Lower Urinary Tract Dysfunction Database

Who Can Participate

Age: 18Years - 90Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient of Balgrist University Hospital
  • Patient of University Hospital Zürich
  • Underwent urodynamic examination
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • No written informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - Initial assessment period

Participants undergo clinical, video-urodynamic, and radiological assessments to characterize their lower urinary tract dysfunction.

1 to 2 visits depending on clinical needs

Long-term Monitoring

Duration - Up to several years until study completion

Participants are followed over time to monitor their condition and treatment outcomes, including survival from the first visit until death.

Ongoing visits as clinically indicated

Trial Site Locations

Total: 1 location

1

Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital

Zurich, Canton of Zurich, Switzerland, 8008

Actively Recruiting

Loading map...

Research Team

T

Thomas M Kessler, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Prophylactic Antibiotics After Neurogenic Overactive Bladder...

Neurogenic Bladder

Actively Recruiting

1 location

Multicentre Randomised Double-blind Superiority Trial to Ass...

Neurogenic Bladder

Actively Recruiting

1 location

Concomitant Renal and Urinary Bladder Allograft Transplantat...

Chronic Kidney Diseases

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.

Lorenz Leitner, Sharmistha Guggenbühl-Roy, Stephanie C Knüpfer...

https://pubmed.ncbi.nlm.nih.gov/27106070